Cargando…

Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamsters

BACKGROUND: Convalescent plasma (CP) transfusion is an early option for treating infections with pandemic potential, often preceding vaccine or antiviral drug rollout. Heterogenous findings from randomized clinical trials on transfusion of COVID-19 CP (CCP) have been reported. However, meta-analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wouters, Elise, Verbrugghe, Caro, Abdelnabi, Rana, Devloo, Rosalie, De Clippel, Dorien, Jochmans, Dirk, De Bleser, Dominique, Weynand, Birgit, Compernolle, Veerle, Neyts, Johan, Feys, Hendrik B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171892/ https://www.ncbi.nlm.nih.gov/pubmed/37148586 http://dx.doi.org/10.1016/j.ebiom.2023.104597

Ejemplares similares

A novel competition ELISA for the rapid quantification of SARS‐CoV‐2 neutralizing antibodies in convalescent plasma
por: Wouters, Elise, et al.
Publicado: (2021)

Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model
por: Foo, Caroline S., et al.
Publicado: (2022)

Nirmatrelvir-resistant SARS-CoV-2 is efficiently transmitted in female Syrian hamsters and retains partial susceptibility to treatment
por: Abdelnabi, Rana, et al.
Publicado: (2023)

Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters
por: Abdelnabi, Rana, et al.
Publicado: (2022)

Impact of cold storage on platelets treated with Intercept pathogen inactivation
por: Six, Katrijn R., et al.
Publicado: (2019)

Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model
por: Abdelnabi, Rana, et al.
Publicado: (2021)

The ice recrystallization inhibitor polyvinyl alcohol does not improve platelet cryopreservation
por: Six, Katrijn R., et al.
Publicado: (2019)

A comparison of haematopoietic stem cells from umbilical cord blood and peripheral blood for platelet production in a microfluidic device
por: Six, Katrijn R., et al.
Publicado: (2019)

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
por: Six, Katrijn R., et al.
Publicado: (2017)

The senotherapeutic nicotinamide riboside raises platelet nicotinamide adenine dinucleotide levels but cannot prevent storage lesion
por: Delabie, Willem, et al.
Publicado: (2019)

A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection
por: Abdelnabi, Rana, et al.
Publicado: (2022)

The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters
por: Abdelnabi, Rana, et al.
Publicado: (2022)

The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern
por: Abdelnabi, Rana, et al.
Publicado: (2022)

Single step method for high yield human platelet lysate production
por: Delabie, Willem, et al.
Publicado: (2022)

Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters
por: Abdelnabi, Rana, et al.
Publicado: (2021)

The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model
por: Abdelnabi, Rana, et al.
Publicado: (2021)

Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters
por: Abdelnabi, Rana, et al.
Publicado: (2023)

Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters
por: Sharma, Sapna, et al.
Publicado: (2022)

HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect
por: Foo, Caroline S., et al.
Publicado: (2022)

Platelet Biochemistry and Morphology after Cryopreservation
por: Six, Katrijn R., et al.
Publicado: (2020)

Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary
por: Wouters, Elise, et al.
Publicado: (2020)

Towards antivirals against chikungunya virus
por: Abdelnabi, Rana, et al.
Publicado: (2015)

Antiviral Strategies Against Chikungunya Virus
por: Abdelnabi, Rana, et al.
Publicado: (2015)

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
por: Boudewijns, Robbert, et al.
Publicado: (2020)

Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity
por: Kaptein, Suzanne J. F., et al.
Publicado: (2020)

Repurposing Drugs for Mayaro Virus: Identification of EIDD-1931, Favipiravir and Suramin as Mayaro Virus Inhibitors
por: Langendries, Lana, et al.
Publicado: (2021)

Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model
por: Imbrechts, Maya, et al.
Publicado: (2022)

ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model
por: Vandyck, Koen, et al.
Publicado: (2021)

Pathogenesis and Host Response in Syrian Hamsters following Intranasal Infection with Andes Virus
por: Safronetz, David, et al.
Publicado: (2011)

Effect of Prophylactic Use of Intranasal Oil Formulations in the Hamster Model of COVID-19
por: Rizvi, Zaigham Abbas, et al.
Publicado: (2021)

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters
por: Boudewijns, Robbert, et al.
Publicado: (2022)

The path towards effective antivirals against rabies
por: Jochmans, Dirk, et al.
Publicado: (2019)

Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models
por: Ma, Ji, et al.
Publicado: (2022)

Impact of disasters on blood donation rates and blood safety: A systematic review and meta‐analysis
por: Laermans, Jorien, et al.
Publicado: (2022)

Intervention strategies for emerging viruses: use of antivirals
por: Debing, Yannick, et al.
Publicado: (2013)

A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE
por: Jochmans, Dirk, et al.
Publicado: (2012)

Volume-Associated Clinical and Histopathological Effects of Intranasal Instillation in Syrian Hamsters: Considerations for Infection and Therapeutic Studies
por: Forero, Catalina, et al.
Publicado: (2022)

Intranasal delivery of a rationally attenuated SARS-CoV-2 is immunogenic and protective in Syrian hamsters
por: Liu, Shufeng, et al.
Publicado: (2022)

Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection
por: Baldeon Vaca, Gabriela, et al.
Publicado: (2023)

Cystolithiasis in a Syrian hamster: a different outcome
por: Petrini, D., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_eu94mp81qes9o08lj28te96a6a